Skip to main content

Peer Review reports

From: Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo

Original Submission
1 Nov 2016 Submitted Original manuscript
10 Nov 2016 Author responded Author comments - Marie Buchholz
Resubmission - Version 2
10 Nov 2016 Submitted Manuscript version 2
15 Dec 2016 Reviewed Reviewer Report - Alexander Beatty
22 Dec 2016 Reviewed Reviewer Report - Linara Gabitova
20 Jan 2017 Author responded Author comments - Marie Buchholz
Resubmission - Version 3
20 Jan 2017 Submitted Manuscript version 3
9 Mar 2017 Author responded Author comments - Marie Buchholz
Resubmission - Version 4
9 Mar 2017 Submitted Manuscript version 4
Publishing
17 Mar 2017 Editorially accepted
24 Mar 2017 Article published 10.1186/s12885-017-3204-x

You can find further information about peer review here.

Back to article page